NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Cost-Benefit Analysis Remove constraint Subjects: Cost-Benefit Analysis

Search Results

41. Inotersen and patisiran for hereditary transthyretin amyloidosis: effectiveness and value : final evidence report

42. Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer: effectiveness and value : final evidence report

43. Prophylaxis for hereditary angioedema with lanadelumab and C1 Inhibitors: effectiveness and value : final evidence report

44. Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report

45. Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report

46. Cost containment in Medicare: a review of what works and what doesn't

47. Challenges to sustaining California's developmental disability services system

48. California's nurse practitioners: how scope of practice laws impact care

49. What difference does Medicaid make?: assessing cost effectiveness, access, and financial protection under Medicaid for low-income adults